CYP1A2 – a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients

Overview of attention for article published in BMC Cancer, March 2016

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter: 8 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 41 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Opus Materia, 28 Jun 2016

Endocrine resistance is a major obstacle to optimal treatment effect in breast cancer. Some genetic markers have been proposed…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.